Eseroline: A new antinociceptive agent derived from physostigmine with opiate receptor agonist properties. Experimental in vivo and in vitro studies on cats and rodents
- 1 September 1981
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 25 (2) , 179-183
- https://doi.org/10.1016/0304-3940(81)90328-1
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Inhibition of [3H]naloxone binding in homogenates of rat brain by eseroline, a drug, with analgesic activity, related to physostigmineJournal of Pharmacy and Pharmacology, 1979
- EFFECTS OF MORPHINE, PHYSOSTIGMINE AND RAPHE NUCLEI STIMULATION ON 5‐HYDROXYTRYPTAMINE RELEASE FROM THE CEREBRAL CORTEX OF THE CATBritish Journal of Pharmacology, 1979
- RAT VAS DEFERENS: A SPECIFIC BIOASSAY FOR ENDOGENOUS OPIOID PEPTIDESBritish Journal of Pharmacology, 1978
- THE MECHANISM OF PLACEBO ANALGESIAThe Lancet, 1978
- Facilitation de réactions nociceptives par la naloxone chez la souris et chez le ratPsychopharmacology, 1974
- A new example of a morphine‐sensitive neuro‐effector junction: adrenergic transmission in the mouse vas deferensBritish Journal of Pharmacology, 1972
- A comparison of the antinociceptive actions of cholinomimetic and morphine‐like drugsBritish Journal of Pharmacology, 1970
- Anticholinesterase Activity of Some Degradation Products of PhysostigmineJournal of Pharmaceutical Sciences, 1970
- The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea‐pig ileum longitudinal muscle stripBritish Journal of Pharmacology, 1969
- The Analgetic Action of Morphine, Eserine and Prostigmine Studied by a Modified Hardy‐Wolff‐Goodell Method.Acta Physiologica Scandinavica, 1945